Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 32029509

Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children's Oncology Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Haematologica
Publication date
2020 Jul
First author
Aplenc R

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Aplenc R
      type
      Author
    2. name
      Meshinchi S
      type
      Author
    3. name
      Sung L
      type
      Author
    4. name
      Alonzo T
      type
      Author
    5. name
      Choi J
      type
      Author
    6. name
      Fisher B
      type
      Author
    7. name
      Gerbing R
      type
      Author
    8. name
      Hirsch B
      type
      Author
    9. name
      Horton T
      type
      Author
    10. name
      Kahwash S
      type
      Author
    11. name
      Levine J
      type
      Author
    12. name
      Loken M
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Aplenc R
      type
      Author
    2. name
      Meshinchi S
      type
      Author
    3. name
      Sung L
      type
      Author
    4. name
      Alonzo T
      type
      Author
    5. name
      Choi J
      type
      Author
    6. name
      Fisher B
      type
      Author
    7. name
      Gerbing R
      type
      Author
    8. name
      Hirsch B
      type
      Author
    9. name
      Horton T
      type
      Author
    10. name
      Kahwash S
      type
      Author
    11. name
      Levine J
      type
      Author
    12. name
      Loken M
      type
      Author
    bibliography ids
    1. nci-bib-9964642da5f4d56f49689aeb
    book metadata
    content sha256
    b3c013afba4ddc1b410fb177672259630b7265cfa33f5caaf7d420e6f13f1307
    document type
    citation
    dois
    1. 10.3324/haematol.2019.220962
    electronic publication date
    display
    2020 Feb 6
    precision
    day
    year
    2020
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:32029509
    immutable id
    pubmed:32029509@b3c013afba4ddc1b410fb177672259630b7265cfa33f5caaf7d420e6f13f1307
    journal
    abbreviation
    Haematologica
    issn electronic
    1592-8721
    issn print
    0390-6078
    issue
    7
    name
    Haematologica
    nlm unique id
    0417435
    pages
    1879-1886
    volume
    105
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      32029509
      provenance
      batch id
      4c5003fbb78890e89ae1
      provider
      NCBI PubMed ESummary
      record sha256
      f070f4dc0e008e1b427af551a164093790eb0e9ba9bbfe844dcfbe6f94d47322
      response sha256
      890389583ce193a9c74e19c63678e418dad2088e82cb704b888b02fcc887d269
      retrieved at
      2026-09-09T23:47:48.270700+00:00
      publication date
      display
      2020 Jul
      precision
      month
      year
      2020
      publication types
      1. Journal Article
      2. Randomized Controlled Trial
      3. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/32029509/
      title
      Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children's Oncology Group.

      Preserved source evidence · Not medical advice